PE/VC investors

Private Equity (PE) and Venture Capital (VC) investors are the catalysts of innovation and growth in the business world. PE firms primarily target established companies, seeking to optimize operations and unlock value through strategic investments and management expertise. They focus on long-term growth and profitability, often preparing businesses for a future sale or IPO. VC investors, by contrast, are the adventurers of finance, injecting capital into high-potential startups and early-stage companies. They embrace risk for the possibility of outsized returns, often becoming invaluable advisors. Both investor types not only bring capital but also strategic guidance, industry connections, and market insights, propelling their portfolio companies towards success.

Investors (7,940)
Investor
Description
More information
TVM Capital Healthcare TVM Capital Healthcare
TVM Capital Healthcare is an emerging markets-focused healthcare private equity investment firm. The organization invests growth capital and focuses on specialized healthcare services, digital health solutions, pharmaceuticals, medical devices, and diagnostics. Investment and operating partners have strong track records in international healthcare M&A and operations. Headquartered in Singapore and Dubai, with representative offices in Munich and Boston, the firm partners with Southeast Asian management teams to build sector champions. TVM Capital Healthcare’s investment approach combines strong commercial value creation and returns with responsible investing. The firm’s comprehensive ESG framework contributes to the creation of impactful, sustainable, and well-governed companies that deliver excellent healthcare services, continued growth, and create high-quality jobs for healthcare professionals in a fair and diverse workplace. TVM Capital Healthcare is a UN PRI signatory since 2015 and a long-standing member of GPCA and recently EPiHC (Ethical Principles in healthcare) an IFC (International Finance Corporation) Initiative, as well as 2X Global and GIIN.
View
TVM Capital Life Science TVM Capital Life Science
TVM Capital Life Science is a venture capital firm based in Munich, Germany, founded in 1983. The firm specializes in life sciences investments, focusing on early-stage therapeutics and commercial-stage medtech, diagnostics, and digital health products. TVM Capital Life Science has a strategic relationship with Eli Lilly and Company, which enhances its ability to support innovative healthcare companies. The team comprises experienced professionals with over 100 years of combined venture capital and industry expertise. The firm invests primarily in the life sciences sector, including biotechnology, pharmaceuticals, and medical devices. TVM Capital Life Science typically invests in Series A and B rounds, with a minimum investment size of $1 million. The firm operates globally, with a focus on Europe and North America, and manages assets worth approximately 900 million euros. Notable funds include TVM Life Science Innovation II, a $478 million fund launched in 2018. TVM Capital Life Science's portfolio includes companies such as Access Vascular - surgical devices, Kent Imaging - diagnostic equipment, and LAmAb Biologics - drug discovery. The firm has a track record of successful exits, including IPOs and acquisitions, highlighting its role as a key player in the life sciences venture capital landscape.
View
TVM Capital MENA TVM Capital MENA
TVM is a leading international venture capital firm focused on investing in life science innovations. The company has a highly experienced transatlantic investment team and approximately $900 million under management. TVM’s portfolio focuses on therapeutics and medical technologies from North America and the EU that represent differentiated first-in-class or best-in-class assets with the potential to transform standard of care. TVM pursues a unique two-pronged strategy, financing innovative early-stage therapeutics through a single asset company approach (Project-Focused Company, PFC) that leverages the firm’s strategic relationship with global pharmaceutical firm, Eli Lilly and Company. TVM also invests in differentiated commercial-stage medical technologies and late clinical-stage therapeutics. The TVM investment team has worked together for over a decade to effectively utilize this innovative approach to maximize returns for investors and finance new therapies and technologies to meaningfully improve patient lives.
View
TVS Capital Funds Limited TVS Capital Funds Limited
TVS Capital Funds has been empowering next gen entrepreneurs with management capability and capital to build companies of extraordinary value since 2007. The fund’s sponsors are TVS Group and Shriram Group who bring with them a proven business culture, infrastructure and a wide network of relationships across sectors and geographies. Led by Gopal Srinivasan of the TVS Group, TCF manages the TVS Shriram Growth Fund which has raised over INR 3,000 Cr across three funds (1A, 1B, & 3). The fund backs consumption driven businesses in Financial Services, Food and Lifestyle and empowers them to help them reach their full potential. Being amongst the largest Rupee Capital Funds, our sector focus combined with an established network of advisors, enables us to maximize the value we provide to entrepreneurs.
View
Twelve Below Twelve Below
Twelve Below is a venture capital firm based in New York, founded in 2021. The firm is led by two partners who have previously co-led investments in companies like Mirror and K Health. They focus on pre-seed and seed stage investments, providing $1M to $3M checks to ambitious teams. The firm prides itself on being a hands-on partner, helping founders unlock their greatest potential. Twelve Below invests primarily in software-enabled sectors, with a focus on health, fintech, consumer, AI, and biotech industries. They limit their portfolio to 25 core companies, taking 10-15% stakes. The firm is a Registered Investment Adviser (RIA) and actively seeks new investments within the USA. Notable investments by Twelve Below include Accrue - savings platform, Arya Health - healthcare software, Aston Labs - biotech company, Caladan Bio - biotechnology, and Conduit Health - healthcare distributor. These investments highlight their commitment to supporting innovative companies in their early stages.
View
Twenty Seven Ventures Twenty Seven Ventures
Twenty Seven Ventures (27V) is a venture capital firm based in Grand Cayman, Cayman Islands, founded in 2019. The firm is led by Atin Batra and focuses on investing in the EdTech and Future of Work sectors. 27V operates with a unique 'Founder Fellowship' approach, fostering a community where founders and their teams can learn from each other. The firm invests at the pre-seed and seed stages, providing not just capital but also facilitating connections and group learning among founders. 27V invests primarily in North America, Europe, and Asia Pacific, excluding India and China. The firm typically writes first checks ranging from $25,000 to $250,000 and reserves capital for follow-on investments. Their investment strategy is centered around early-stage startups in the education technology and future of work domains. 27V does not lead rounds but supports founders with a long-term, patient company-building approach. Notable investments by 27V include companies such as 101Edu - an education company, Alpe Audio - an education app, and New Campus - an education website. These investments reflect the firm's commitment to backing innovative solutions in the learning and labor sectors.
View
Twenty65 Twenty65
Twenty65 is a UK-focused initiative specializing in water innovation and sustainable water solutions. Established in collaboration with the Engineering and Physical Sciences Research Council (EPSRC) from 2016 to 2021, it brings together academic researchers and industry partners to tackle prevailing water management challenges. Based in Sheffield, the team comprises leading academics, including Prof Joby Boxall and Prof Vanessa Speight from the University of Sheffield, and aims to foster cross-sectoral collaboration to drive impactful changes in the water sector. The initiative focuses on developing technologies that address the economic, sociological, and ecological challenges within the water cycle. It employs a multidisciplinary approach to design and implement scalable solutions that enhance water system resilience and adaptability. While Twenty65 does not directly serve as an investment firm, it plays a crucial role in promoting innovations through partnerships with more than 40 entities across the international water sector. Notable contributions of Twenty65 include advancing demand-based water treatment technologies, minimizing carbon emissions through synergistic systems, and employing robotics for improved water management. These innovations have significant implications for public health and environmental sustainability, positioning Twenty65 as a key player in pioneering next-generation water solutions.
View
Twentytwo VC Twentytwo VC
Twentytwo VC is a venture capital firm based in San Francisco, California, founded in 2017 by Katey Caldwell. The firm specializes in early-stage investments, particularly in SaaS, fintech, open source, marketplaces, and developer tools. With a small team, Twentytwo VC prides itself on making quick investment decisions and supporting ambitious founders who are building exceptional companies. The firm focuses on seed-stage and early-stage investments, with typical check sizes ranging from $50,000 to $250,000. Twentytwo VC invests primarily in the USA, Latin America, and the Asia-Pacific region. The firm manages over $20 million across multiple funds, emphasizing sectors such as SaaS, fintech, and AI. Notable portfolio companies include PostHog - an open-source product operating system platform, Routable - payment automation and scaling, and Zip - procurement software. These investments highlight Twentytwo VC's commitment to supporting innovative technology startups.
View
Twin Bridge Capital Partners Twin Bridge Capital Partners
Founded in 2005 and based in Chicago, IL, Twin Bridge Capital Partners is an independent private equity firm focused on investing in North American small and lower middle market companies through buyout funds and direct equity investments spanning co-investments and GP-led secondary investments. Twin Bridge invests through traditional fund structures targeting (i) Small Market Buyouts, (ii) Lower Middle Market Buyouts and (iii) GP-led Secondary Buyouts, as well as customized separate accounts. Twin Bridge has raised more than $5.4B of committed capital from numerous institutional and high-net-worth investors.
View
Twine Ventures Twine Ventures
Twine Ventures is a venture capital firm based in San Francisco, California, founded in 2021 by Leshika Samarasinghe and Ethan Yeh. Leshika has a background in early product teams at Google and was a founding member of ARPA-E, while Ethan was a former Head of Data Science at Stripe and director at Twitter. The firm is known for its hands-on approach, partnering with founders from the earliest stages to drive competitive Series A fundraises. Twine Ventures focuses on sectors such as healthcare, climate, and financial empowerment, investing in interdisciplinary teams that leverage data and AI. They typically write first checks ranging from $250K to $1M, targeting seed and Series A stages. The firm invests primarily in the USA and has a portfolio that includes companies like Airship, Alaffia, and Alchemy. Twine Ventures does not lead rounds but provides co-investment access and support for women and BIPOC founders. Notable investments by Twine Ventures include Airship - sales enablement software for HVAC professionals, Alaffia - AI-based payment integrity for healthcare, Alchemy - tech-enabled pharmacy for underserved populations, Alden - staffing optimization for home care, and Alpha Grid - pricing intelligence for EV charging infrastructure.
View

Investor Database: Find Angel Investors, VCs & Private Equity Firms

Find angel investors, venture capital firms, and private equity investors worldwide.

Search thousands of active investors by stage, industry, and location. Built for founders, fundraising teams, and M&A advisors who need relevant investors fast.

Database at a Glance

  • 7,000+ investors
  • 118 countries covered
  • Angels, venture capital, and private equity in one platform
  • Filter by stage, industry, and location

A Searchable Directory of Active Investors

This is a global investor database built for fast, targeted discovery.

Instead of spreadsheets or generic lists, you can search verified angel investors, venture capital firms, and private equity funds actively investing across markets, industries, and stages.

Everything is structured to help you identify relevant investors quickly and move straight to outreach.

Private Equity List’s AI Search tool lets you describe your company or deal and returns investors with matching investment history, so you are not guessing who might be a fit.

Investor Database With Actionable Data

Every profile is designed to help you assess fit without unnecessary digging.

Each investor profile includes:

  • Investor or firm name
  • Investor type (Angel, Venture Capital, Private Equity)
  • Country and geographic focus
  • Investment stage preference
  • Industry and sector focus

This allows you to shortlist investors based on real criteria, not assumptions.

Global Coverage Across Angels, VC, and Private Equity

The directory supports fundraising and deal sourcing across regions and investor types.

  • Thousands of investors listed worldwide
  • Coverage across multiple countries
  • Angel investors, VC firms, and PE funds in one place
  • Continuously expanding investor coverage

Whether you’re raising early-stage capital or sourcing institutional investors, the database scales with your needs.

Filter Investors by Stage, Industry, and Location

Finding the right investors shouldn’t require manual sorting.

You can filter investors by:

  • Investor type (Angel, VC, Private Equity)
  • Industry and sector
  • Investment stage
  • Country and location

These filters help you focus only on investors aligned with your raise or transaction.

Built for Founders, Fundraising Teams, and Advisors

This investor database is designed for people actively sourcing capital or investors.

Startup Founders

Find investors aligned with your stage, sector, and geography. Build targeted investor lists and reduce time spent on cold outreach.

Fundraising and Growth Teams

Accelerate investor research, improve targeting, and support active fundraising with structured data.

M&A Advisors and Dealmakers

Identify investors and capital partners across regions and deal types. Source active capital faster with better precision.

Search, Shortlist, and Start Outreach

Using the database is straightforward and built for speed.

  1. Search investors using filters for stage, industry, and location
  2. Build a targeted investor shortlist
  3. Begin outreach or deal sourcing

Start Searching Investors Today

Access a global database of angel investors, venture capital firms, and private equity funds built for high-intent fundraising.

Our AI Search tool helps you quickly identify the most relevant investors based on stage, sector, geography, and real investment behaviour.

Search Investors

FAQs

An investor database typically includes structured investment data such as investor type, geographic focus, preferred investment stage, and industry or sector interests.
Yes, most comprehensive investor databases include angel investors alongside venture capital firms, private equity funds, and other early-stage investment sources.
The insight provided depends on how frequently the database is updated, but profiles generally reflect publicly available information on investment focus, stage, and location.
Yes, many investor databases include family office investors, allowing users to identify them by location, investment focus, and deal type.
Investor databases are commonly used by startup founders, fundraising teams, and advisors who need a structured way to research and identify relevant investors.